NH suit makes future uncertain for drug firm that raised price of medicine 100 fold




Amid everything else, the company has a date with the U.S. Supreme Court on March 19. URL Pharma's Mutual Pharmaceuticals subsidiary is contesting a New Hampshire court decision that gave $21 million to a woman who nearly died after taking the Mutual drug sulindac for shoulder pain.
CLICK TO VIEW THE SOURCE MATERIAL


Post a comment


You must sign in before you can post comments. If you are experiencing issues with your account please e-mail abuse@unionleader.com.